Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic agents associated with QT interval prolongation.

Keith M Olsen1

  • 1University of Nebraska Medical Center, Omaha, NE, USA.

The Journal of Family Practice
|June 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Importance of Residency Training for the Provision of Comprehensive Clinical Pharmacy Services.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Executive Summary: Society of Critical Care Medicine Guidelines on Recognizing and Responding to Clinical Deterioration Outside the ICU.

Critical care medicine·2024
Same author

Society of Critical Care Medicine Guidelines on Recognizing and Responding to Clinical Deterioration Outside the ICU: 2023.

Critical care medicine·2024
Same author

The authors reply.

Critical care medicine·2022
Same author

Pharmacist-Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review.

Frontiers in pharmacology·2021
Same author

The Society of Critical Care Medicine at 50 Years: Interprofessional Practice in Critical Care: Looking Back and Forging Ahead.

Critical care medicine·2021

Certain medications can prolong the QT interval, increasing the risk of dangerous heart rhythms. Doctors should avoid prescribing multiple QT-prolonging drugs to high-risk patients to prevent adverse events.

Area of Science:

  • Cardiology
  • Clinical Pharmacology

Background:

  • Medications can affect cardiac repolarization.
  • QT interval prolongation is linked to serious arrhythmias.

Purpose of the Study:

  • To highlight the risk of drug-induced QT interval prolongation.
  • To provide guidance on minimizing associated adverse events.

Main Methods:

  • Review of medication classes associated with QT prolongation.
  • Analysis of patient risk factors for ventricular arrhythmias.

Main Results:

  • Multiple drug classes are implicated in QT interval prolongation.
  • High-risk patients are susceptible to fatal arrhythmias from these drugs.

Related Experiment Videos

Conclusions:

  • Concurrent prescription of QT-prolonging medications poses a significant risk.
  • Careful medication selection in high-risk individuals is crucial for patient safety.